NCT01486537CompletedNot Applicable
Characterization of Blood Drawn From the Pulp of Primary Molar Undergoing Pulpotomy or Pulpectomy.
Hadassah Medical Organization1 site in 1 country87 target enrollmentStarted: December 2011Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 87
- Locations
- 1
Study Overview
Brief Summary
The aim of this study is to evaluate the level of acidity of blood samples that are been taken from pulp chambers of primary molars undergoing pulpotomy or pulpectomy procedures. Our hypothesis is that samples from teeth undergoing pulpectomy would be acidic while samples from teeth undergoing pulpotomy would bo neutral.
Detailed Description
The samples will be collected by 1 m"l syringe that is pre-washed with Heparin.than the samples will be analyzed in an Astrop machine of neonates.
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 3 Years to 13 Years (Child)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •no systemic disease
- •teeth that are undergoing pulpotomy or pulpectomy
Exclusion Criteria
- •systemic disease
- •pulp necrosis
- •permanent teeth
Investigators
Moti Moskovitz
dr
Hadassah Medical Organization
Study Sites (1)
Loading locations...
Similar Trials
Withdrawn
Not Applicable
Characterization of Blood Drawn From the Pulp of Primary Molar Undergoing Pulpotomy or Pulpectomy.Inflammatory MarkersPulpotomyNCT01878851Hadassah Medical Organization
Not yet recruiting
Not Applicable
A study of blood count of primary teeth during pulp therapy.CTRI/2022/10/046299SGT University
Recruiting
Not Applicable
Biobank Carcinoma: Storing Blood and Protein of Patients With CancerCancerNCT01084785Maastricht Radiation Oncology10,000
Recruiting
Not Applicable
Multi-analyte Blood Test Clinical TrialHCCHepatocellular CarcinomaLiver CirrhosisLiver CancerNCT05199259Helio Genomics1,200
Withdrawn
Not Applicable
Multi-disease Carrier Screening Test ValidationSpinal Muscular Atrophy (SMA)Carrier ScreeningGenetic TestingNCT01663584Natera, Inc.